New Delhi [India], July 6 (ANI): The Indian drug regulator has urged Pfizer twice in writing to apply for emergency use authorization for its COVID-19 vaccine so that the application is processed well in time but Pfizer has not applied for the license yet, said sources on Tuesday.
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday.
London [UK], June 4 (ANI): United Kingdom's drug regulator on Friday informed that it had approved the COVID-19 vaccine developed by Pfizer and BioNTech for use on 12 to 15 year-olds after similar clearances were given in the US and the EU.
New Delhi [India], May 30 (ANI): The cost of Monoclonal antibody therapy, which was recently approved by India's top drug regulatory body for treatment of COVID-19, can be lowered if a very efficient system for its manufacturing is developed, said Dr Nirmal K Ganguly, former Director-General
Islamabad [Pakistan], May 30 (ANI): The Drug Regulatory Authority of Pakistan (Drap) is rushing to register the Pfizer COVID-19 vaccine, after a shipment with 100,000 doses of the vaccine arrived in the country, under the COVAX initiative, without any clearance.
Islamabad [Pakistan], March 22 (ANI): The Federal Cabinet in Pakistan has approved the highly expensive prices recommended by the Drug Regulatory Authority of Pakistan (DRAP) for COVID-19 vaccines imported by private companies.
New Delhi [India], January 28 (ANI): India's drug regulatory body has received requests from both Pune based Serum Institute of India and Hyderabad-based Bharat Biotech to make necessary changes in the vaccine fact sheet to allow people using blood thinners to get inoculated against Covid-19
Islamabad [Pakistan], January 24 (ANI): Pakistan's Drug Regulatory Authority has approved the emergency use of the Russian-made vaccine against the coronavirus disease, Gam-COVID-Vac, commonly known as Sputnik V.
Islamabad [Pakistan], January 19 (ANI): The Drug Regulatory Authority of Pakistan (Drap) on Monday approved Chinese state-owned firm Sinopharm's COVID-19 vaccine for emergency use, the second vaccine to be given approval for use in the country, reported Dawn.
New Delhi [India], January 4 (ANI): After the drug regulator of the country gave in principle approval for restricted emergency use to two indigenously made vaccines, Bharatiya Janata Party (BJP) spokesperson Sambit Patra on Monday said that when India's scientists develop things for public